Lilly Covid antibodies cut hospitalizations and deaths
US pharmaceutical company Eli Lilly’s combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in
Read more
US pharmaceutical company Eli Lilly’s combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in
Read morePharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University
Read moreA drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based
Read moreColon cancer cases on the rise for people under 50, doctors say While colon cancer isn’t often diagnosed in those
Read more